Trial Details
RECRUITINGBasic Information
| Clinical ID | c1643 |
|---|---|
| Identifier | NCT04373473 |
| Trial Title | Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Adults With Ulcerative Colitis |
| Interventions | DRUG: PRIM-DJ2727|DRUG: Placebos |
Participant Information
| Sponsor | The University of Texas Health Science Center, Houston |
|---|---|
| City | Houston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-09-14 |
|---|---|
| Primary Completion Date | 2025-12-31 |
| Completion Date | 2025-12-31 |